Almawave SpA
MIL:AIW
Almawave SpA
MIL:AIW
Price:
4.29
EUR
Market Closed
Market Cap:
€128.6m
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
Almawave SpA
MIL:AIW
|
IT |
|
Swedish Orphan Biovitrum AB (publ)
STO:SOBI
|
SE |
|
Saudi Real Estate Company SJSC
SAU:4020
|
SA |
|
Greenlam Industries Ltd
NSE:GREENLAM
|
IN |
|
Zhong Yang Technology Co Ltd
TWSE:6668
|
TW |
|
Sajodongaone Co Ltd
KRX:008040
|
KR |
|
I
|
ImmunoGen Inc
XETRA:IMU
|
US |
Balance Sheet
Balance Sheet Decomposition
Almawave SpA
Almawave SpA
Balance Sheet Decomposition is not available for
Almawave SpA
Almawave SpA
Balance Sheet
Almawave SpA
Almawave SpA
Currency: EUR
| Dec-2016 | Dec-2017 | Dec-2018 | Dec-2019 | Dec-2020 | Dec-2021 | Dec-2022 | Dec-2023 | Dec-2024 | ||
|---|---|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||||
| Cash & Cash Equivalents |
0
|
2
|
1
|
1
|
2
|
15
|
10
|
9
|
6
|
|
| Cash Equivalents |
0
|
2
|
1
|
1
|
2
|
15
|
10
|
9
|
6
|
|
| Short-Term Investments |
0
|
0
|
1
|
1
|
1
|
0
|
1
|
1
|
0
|
|
| Total Receivables |
10
|
10
|
14
|
18
|
21
|
26
|
39
|
46
|
50
|
|
| Accounts Receivables |
10
|
10
|
14
|
18
|
21
|
26
|
39
|
46
|
48
|
|
| Other Receivables |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
1
|
|
| Inventory |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Current Assets |
5
|
6
|
6
|
7
|
6
|
8
|
6
|
8
|
11
|
|
| Total Current Assets |
15
|
17
|
21
|
27
|
30
|
50
|
57
|
65
|
66
|
|
| PP&E Net |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| PP&E Gross |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Accumulated Depreciation |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
1
|
|
| Intangible Assets |
11
|
13
|
14
|
17
|
18
|
20
|
23
|
29
|
36
|
|
| Goodwill |
0
|
0
|
0
|
0
|
0
|
0
|
19
|
24
|
24
|
|
| Long-Term Investments |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Long-Term Assets |
1
|
1
|
1
|
0
|
0
|
0
|
0
|
1
|
1
|
|
| Other Assets |
0
|
0
|
0
|
0
|
0
|
0
|
19
|
24
|
24
|
|
| Total Assets |
27
N/A
|
31
+14%
|
37
+17%
|
44
+21%
|
49
+11%
|
70
+42%
|
101
+43%
|
118
+17%
|
127
+7%
|
|
| Liabilities | ||||||||||
| Accounts Payable |
6
|
6
|
8
|
12
|
19
|
23
|
30
|
34
|
36
|
|
| Accrued Liabilities |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Short-Term Debt |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Current Portion of Long-Term Debt |
11
|
13
|
17
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Current Liabilities |
4
|
4
|
3
|
5
|
4
|
4
|
7
|
7
|
8
|
|
| Total Current Liabilities |
21
|
23
|
27
|
17
|
23
|
27
|
37
|
41
|
44
|
|
| Long-Term Debt |
0
|
0
|
0
|
15
|
15
|
0
|
1
|
3
|
2
|
|
| Deferred Income Tax |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Minority Interest |
1
|
1
|
1
|
1
|
0
|
0
|
0
|
0
|
0
|
|
| Other Liabilities |
3
|
2
|
2
|
3
|
3
|
2
|
3
|
4
|
4
|
|
| Total Liabilities |
24
N/A
|
27
+10%
|
30
+13%
|
36
+19%
|
41
+13%
|
29
-28%
|
40
+38%
|
48
+20%
|
50
+3%
|
|
| Equity | ||||||||||
| Common Stock |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Retained Earnings |
3
|
5
|
6
|
8
|
9
|
39
|
57
|
66
|
73
|
|
| Other Equity |
0
|
0
|
0
|
0
|
0
|
1
|
3
|
3
|
3
|
|
| Total Equity |
3
N/A
|
5
+48%
|
7
+40%
|
8
+27%
|
9
+5%
|
41
+366%
|
60
+47%
|
70
+16%
|
77
+10%
|
|
| Total Liabilities & Equity |
27
N/A
|
31
+14%
|
37
+17%
|
44
+21%
|
49
+11%
|
70
+42%
|
101
+43%
|
118
+17%
|
127
+7%
|
|
| Shares Outstanding | ||||||||||
| Common Shares Outstanding |
26
|
26
|
26
|
26
|
26
|
27
|
29
|
30
|
30
|
|
Switch to:
Switch to:
See Also
Discover More
